Department of Psychiatry, Amsterdam University Medical Center, Amsterdam, the Netherlands; Department of Child and Adolescent Psychiatry, Amsterdam University Medical Center, Amsterdam, the Netherlands.
The Bascule, Academic Centre for Child and Adolescent Psychiatry, Amsterdam, the Netherlands; Department of Child and Adolescent Psychiatry, Amsterdam University Medical Center, Amsterdam, the Netherlands.
Psychoneuroendocrinology. 2019 Nov;109:104380. doi: 10.1016/j.psyneuen.2019.104380. Epub 2019 Jul 17.
Despite availability of effective trauma-focused psychotherapies, treatment non-response in youth with (partial) posttraumatic stress disorder remains substantial. Studies in adult PTSD have suggested that cortisol is associated with treatment outcome. Furthermore, cortisol prior to treatment could be used to predict treatment success. However, there is a lack of comparable studies in youth with (partial) PTSD. The objective of the current study was therefore to test whether cortisol prior to treatment would differ between treatment responders and non-responders and would positively predict the extent of clinical improvement in youth with (partial) PTSD.
Youth aged 8-18 with PTSD (79.2%) or partial PTSD (20.8%) were treated with 8 sessions of either trauma-focused cognitive behavioral therapy (TF-CBT) or eye movement desensitization and reprocessing (EMDR). Prior to treatment initiation, salivary cortisol was measured in treatment responders (n = 23) and treatment non-responders (n = 30) at 10 and 1 min before and 10, 20 and 30 min after personalized trauma script driven imagery (SDI). The cortisol stress response (>1.5 nmol/L increase from baseline) and basal cortisol secretion was assessed during the SDI procedure. We hypothesized that treatment responders would display higher cortisol levels caused by increased cortisol reactivity prior to trauma-focused psychotherapy relative to psychotherapy non-responders and higher cortisol levels would positively predict the extent of clinical improvement.
Script driven imagery did not induce a cortisol stress response in all but two participants. Prior to treatment responders showed significantly higher basal cortisol secretion during SDI compared to treatment non-responders. This effect remained significant after controlling for gender. Higher pre-treatment basal cortisol secretion further positively predicted the extent of clinical improvement during trauma-focused psychotherapy.
Because SDI failed to provoke a cortisol stress response in our sample, the question if cortisol reactivity differs between treatment responders and non-responders remains inconclusive. However, our results do suggest that higher pretreatment basal cortisol secretion forms a potential indicator of prospective trauma-focused psychotherapy response in youth with (partial) PTSD. Although, the amount of uniquely explained variance in clinical improvement by pre-treatment cortisol secretion is limited and still renders insufficient basis for clinical applicability, these findings do suggest directions for future studies to delineate the mechanisms of treatment success in youth with (partial) PTSD.
尽管有有效的创伤聚焦心理疗法,但青少年(部分)创伤后应激障碍的治疗反应仍不充分。成人 PTSD 的研究表明,皮质醇与治疗结果有关。此外,治疗前的皮质醇可以用来预测治疗效果。然而,在青少年(部分)创伤后应激障碍患者中,缺乏类似的研究。因此,本研究的目的是检验治疗前皮质醇是否会在治疗反应者和非反应者之间存在差异,并对青少年(部分)创伤后应激障碍患者的临床改善程度有积极的预测作用。
年龄在 8-18 岁之间的 PTSD(79.2%)或部分 PTSD(20.8%)患者接受了 8 次创伤聚焦认知行为治疗(TF-CBT)或眼动脱敏与再加工(EMDR)治疗。在开始治疗前,对 23 名治疗反应者和 30 名治疗非反应者在个性化创伤脚本驱动意象(SDI)前 10 分钟、1 分钟、10 分钟、20 分钟和 30 分钟时测量唾液皮质醇。在 SDI 过程中评估皮质醇应激反应(基线增加>1.5 nmol/L)和基础皮质醇分泌。我们假设治疗反应者在接受创伤聚焦心理治疗前的皮质醇反应性会增加,导致皮质醇水平升高,而治疗非反应者则不会,且较高的皮质醇水平会积极预测临床改善程度。
除了两名参与者外,SDI 并未引起皮质醇应激反应。治疗前反应者在 SDI 期间的基础皮质醇分泌明显高于治疗非反应者。在控制了性别后,这一效应仍然显著。治疗前基础皮质醇分泌进一步对创伤聚焦心理治疗期间的临床改善程度有积极的预测作用。
由于 SDI 在我们的样本中未能引起皮质醇应激反应,因此治疗反应者和非反应者之间的皮质醇反应性是否存在差异仍不确定。然而,我们的结果确实表明,较高的治疗前基础皮质醇分泌可能是青少年(部分)创伤后应激障碍患者接受创伤聚焦心理治疗反应的一个潜在指标。尽管皮质醇分泌对临床改善的解释程度有限,且仍不足以作为临床应用的基础,但这些发现确实为未来的研究指明了方向,以阐明青少年(部分)创伤后应激障碍患者治疗成功的机制。